SG Americas Securities’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-26,114
| Closed | -$57K | – | 2507 |
|
|
2024
Q1 | $57K | Buy |
+26,114
| New | +$57K | ﹤0.01% | 2401 |
|
|
2022
Q2 | – | Sell |
-14,530
| Closed | -$39K | – | 3062 |
|
|
2022
Q1 | $39K | Buy |
14,530
+4,321
| +42% | +$11.6K | ﹤0.01% | 2515 |
|
|
2021
Q4 | $44K | Sell |
10,209
-20,637
| -67% | -$88.9K | ﹤0.01% | 2877 |
|
|
2021
Q3 | $157K | Buy |
30,846
+19,272
| +167% | +$98.1K | ﹤0.01% | 3125 |
|
|
2021
Q2 | $73K | Sell |
11,574
-1,902
| -14% | -$12K | ﹤0.01% | 2443 |
|
|
2021
Q1 | $104K | Buy |
+13,476
| New | +$104K | ﹤0.01% | 2791 |
|
|
2020
Q4 | – | Sell |
-21,797
| Closed | -$145K | – | 2811 |
|
|
2020
Q3 | $145K | Buy |
21,797
+9,699
| +80% | +$64.5K | ﹤0.01% | 1915 |
|
|
2020
Q2 | $101K | Sell |
12,098
-5,257
| -30% | -$43.9K | ﹤0.01% | 2922 |
|
|
2020
Q1 | $133K | Buy |
+17,355
| New | +$133K | ﹤0.01% | 2360 |
|
|
2018
Q3 | – | Sell |
-5,200
| Closed | -$119K | – | 2625 |
|
|
2018
Q2 | $119K | Buy |
+5,200
| New | +$119K | ﹤0.01% | 2578 |
|
|
2016
Q4 | – | Sell |
-7,478
| Closed | -$117K | – | 2661 |
|
|
2016
Q3 | $117K | Buy |
+7,478
| New | +$117K | ﹤0.01% | 2610 |
|